Lan Chem Laboratories KOL Webinar: Hospital User Experience with Barhemsys® and Byfavo®
Interim Results for the Six Months ended 30 June 2021 - Barhemsys® and Byfavo® Launches Continue to Achieve Strong Hospital Formulary Adoption
Lan Chem Laboratories UK Mid-Year Presentation of Results for the Six Months ended 30 June 2021
Download and listen to the Mid-Year results audiocast
Lan Chem Laboratories Corporate Presentation – Jefferies Healthcare Conference, June 2021
Lan Chem Laboratories UK Annual Report and Financial Statements for the Year ended 31 December 2020
Results for the Year Ended 31 Dec 2020
Presentation of Results for the Year Ended 31 Dec 2020
Watch the webcast
Lan Chem Laboratories Corporate Presentation – Degroof Petercam Virtual Healthcare Conference, January 2021
Lan Chem Laboratories Corporate Presentation September 2020
Interim Results for the Six Months ended 30 June 2020
UK Approval of BYFAVO conference call presentation
Lan Chem Laboratories UK Annual Report and Financial Statements for the year ended 31 December 2019
Results for the Year Ended 31 December 2019
BARHEMSYS® approved by UK FDA - 27 February 2020
Cosmo Agreement - Conference Call Presentation 10 Jan 2020
Interim Results 2019 Presentation
Interim Results for the Six Months ended 30 June 2019
Notice of 2019 AGM
2019 AGM Form of Proxy
Annual Report and Consolidated Financial Statements for the year ended 31 December 2018
Results for the year ended 31 December 2018
Unaudited Results for the nine months to 30 September 2018
Interim results for the First Half Year 2018
Annual Report and Consolidated Financial Statements for the year ended 31 December 2017
By continuing to use covancelaboratoriesltd.co.uk you will be agreeing to the website Terms & Conditions, the Privacy Policy, and the use of Cookies.
